Donepezil improved the clinical state and quality of life in moderate-to-severe Alzheimer disease
- PMID: 11874284
Donepezil improved the clinical state and quality of life in moderate-to-severe Alzheimer disease
Comment on
-
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease.Neurology. 2001 Aug 28;57(4):613-20. doi: 10.1212/wnl.57.4.613. Neurology. 2001. PMID: 11524468 Clinical Trial.